BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33320870)

  • 1. Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit.
    Sedghizadeh MJ; Hojjati H; Ezzatdoost K; Aghajan H; Vahabi Z; Tarighatnia H
    PLoS One; 2020; 15(12):e0243535. PubMed ID: 33320870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific feature of olfactory dysfunction with Alzheimer's disease inspected by the Odor Stick Identification Test.
    Jimbo D; Inoue M; Taniguchi M; Urakami K
    Psychogeriatrics; 2011 Dec; 11(4):196-204. PubMed ID: 22151238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive MMN and P300 in mild cognitive impairment and Alzheimer's disease: A high density EEG-3D vector field tomography approach.
    Papadaniil CD; Kosmidou VE; Tsolaki A; Tsolaki M; Kompatsiaris IY; Hadjileontiadis LJ
    Brain Res; 2016 Oct; 1648(Pt A):425-433. PubMed ID: 27485659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory function in elderly people and patients with Alzheimer's disease.
    Hori Y; Matsuda O; Ichikawa S
    Psychogeriatrics; 2015 Sep; 15(3):179-85. PubMed ID: 25515307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory testing in consecutive patients referred with suspected dementia.
    Christensen IT; Larsson EM; Holm IE; Nielsen OBF; Andersen S
    BMC Geriatr; 2017 Jun; 17(1):129. PubMed ID: 28633628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in Alzheimer's disease with a special emphasis on event-related oscillatory responses.
    Yener GG; Başar E
    Suppl Clin Neurophysiol; 2013; 62():237-73. PubMed ID: 24053044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging.
    Woodward MR; Hafeez MU; Qi Q; Riaz A; Benedict RHB; Yan L; Szigeti K;
    Am J Geriatr Psychiatry; 2018 Aug; 26(8):835-846. PubMed ID: 29858162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intact olfactory memory in the 5xFAD mouse model of Alzheimer's disease from 3 to 15 months of age.
    O'Leary TP; Stover KR; Mantolino HM; Darvesh S; Brown RE
    Behav Brain Res; 2020 Sep; 393():112731. PubMed ID: 32522622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of odorant identification impairment in patients with Alzheimer's Disease.
    Umeda-Kameyama Y; Ishii S; Kameyama M; Kondo K; Ochi A; Yamasoba T; Ogawa S; Akishita M
    Sci Rep; 2017 Jul; 7(1):4798. PubMed ID: 28684764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Smell Identification Deficit with Alzheimer's Disease Assessment Scale-Cognitive Subscale, Japanese Version Scores and Brain Atrophy in Patients with Dementia.
    Yoshii F; Onaka H; Kohara S; Ryo M; Takahashi W
    Eur Neurol; 2019; 81(3-4):145-151. PubMed ID: 31242486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG coherence in Alzheimer's dementia.
    Adler G; Brassen S; Jajcevic A
    J Neural Transm (Vienna); 2003 Sep; 110(9):1051-8. PubMed ID: 12928837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individuals at risk for Alzheimer's disease show differential patterns of ERP brain activation during odor identification.
    Morgan CD; Murphy C
    Behav Brain Funct; 2012 Jul; 8():37. PubMed ID: 22849610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensory Cueing of Autobiographical Memories in Normal Aging and Alzheimer's Disease: A Comparison Between Visual, Auditory, and Olfactory Information.
    Lopis D; Le Pape T; Manetta C; Conty L
    J Alzheimers Dis; 2021; 80(3):1169-1183. PubMed ID: 33646149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness of olfactory deficits in healthy aging, amnestic mild cognitive impairment and Alzheimer's disease.
    Bahar-Fuchs A; Moss S; Rowe C; Savage G
    Int Psychogeriatr; 2011 Sep; 23(7):1097-106. PubMed ID: 21251352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cortical pathway to olfactory naming: evidence from primary progressive aphasia.
    Olofsson JK; Rogalski E; Harrison T; Mesulam MM; Gottfried JA
    Brain; 2013 Apr; 136(Pt 4):1245-59. PubMed ID: 23471695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory-evoked regional cerebral blood flow in Alzheimer's disease.
    Kareken DA; Doty RL; Moberg PJ; Mosnik D; Chen SH; Farlow MR; Hutchins GD
    Neuropsychology; 2001 Jan; 15(1):18-29. PubMed ID: 11216885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
    Meghdadi AH; Stevanović Karić M; McConnell M; Rupp G; Richard C; Hamilton J; Salat D; Berka C
    PLoS One; 2021; 16(2):e0244180. PubMed ID: 33544703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional brain atrophy in patients with mild Alzheimer's disease and delusions.
    Geroldi C; Bresciani L; Zanetti O; Frisoni GB
    Int Psychogeriatr; 2002 Dec; 14(4):365-78. PubMed ID: 12670058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Odorant-induced brain activation as a function of normal aging and Alzheimer's disease: A preliminary study.
    Steffener J; Motter JN; Tabert MH; Devanand DP
    Behav Brain Res; 2021 Mar; 402():113078. PubMed ID: 33359846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.
    Nagy Z; Esiri MM; Jobst KA; Morris JH; King EM; McDonald B; Litchfield S; Smith A; Barnetson L; Smith AD
    Dementia; 1995; 6(1):21-31. PubMed ID: 7728216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.